10-Q · August 14, 2026
The quarter was weak, with negative $3.05 EPS and $2.273 million of revenue versus expectations of negative $2.92 and $2.8 million, respectively. The 10-Q also confirms that disclosure controls remained ineffective as…
10-Q · Filed November 16, 2026 · Our reading of the company's report
The latest report
Q3 revenue increased to $4.685 million from $2 million in Q2 and $3 million a year earlier, but diluted EPS deteriorated to -$17.78 from -$3.05 sequentially and -$1.64 year over year. The filing provides no segment,…
Q3 revenue increased to $4.685 million from $2 million in Q2 and $3 million a year earlier, but diluted EPS deteriorated to -$17.78 from -$3.05 sequentially and -$1.64 year over year. The filing provides no segment, margin, free-cash-flow or quantitative guidance disclosure in the extracted text. The most material concerns are the persistence of 3 internal-control weaknesses, uncertain remediation timing, unquantified litigation exposure and continued equity issuance to settle obligations.
Q3 revenue was $4.685 million, up from $2 million in 2026 Q2 and $3 million in 2025 Q3, indicating sequential and year-over-year growth.
Reported Q3 diluted EPS was -$17.78 versus -$3.05 in 2026 Q2 and -$1.64 in 2025 Q3, showing a substantial deterioration in per-share profitability.
The company implemented a new ERP system during the quarter ended March 31, 2026, with controls covering user access, segregation of duties, change management, transaction processing and period-end reporting.
The company issued 17,973 Class A shares between August 5 and August 18, 2026, upon conversion of approximately $212 thousand of notes, and issued 1,674 shares to settle approximately $22 thousand of Boot Capital obligations.
On July 27, 2026, the company issued 1,645 common shares with a determined fair value of $36 in partial settlement of amounts owed to Verista.
Management concluded disclosure controls were not effective as of September 30, 2026, due to 3 previously disclosed material weaknesses involving IT general controls, entity-level controls and the period-end financial close and reporting process.
Management stated that remediation is ongoing and cannot assure successful remediation in a timely manner; the weaknesses will not be considered remediated until controls operate effectively for a sufficient period and testing is completed.
The Shah v. Banzai litigation is pending under federal case number 5:26-cv-12369, with a preliminary-injunction request and motion to dismiss still pending; counsel could not estimate the likelihood or amount of any potential loss.
The company is named in the Buckheit books-and-records proceeding, Case No. 26CV501477; the proceeding seeks access to corporate records and may involve successor-liability and alter-ego theories, although no monetary loss estimate is available.
The company issued 20,000 shares to a consultant on October 27, 2026, while also converting approximately $212 thousand of notes into 17,973 shares, indicating continued reliance on equity issuance to satisfy obligations and services.
No quantitative revenue or EPS outlook was provided in the extracted 10-Q. Item 1A states that the company is a smaller reporting company and is not required to provide risk-factor information; no forward operating guidance was disclosed.
The quarter was weak, with negative $3.05 EPS and $2.273 million of revenue versus expectations of negative $2.92 and $2.8 million, respectively. The 10-Q also confirms that disclosure controls remained ineffective as…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.
The free pages stop at the last full session. Trader shows every trade as it prints.